oncolytic adenovirus
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for oncolytic adenovirus, covering 2022-10-04 to 2022-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer [Phase 2]